+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
PET Radiotracer Market - Global Forecast 2026-2032- Product Image
PET Radiotracer Market - Global Forecast 2026-2032- Product Image
Sale

PET Radiotracer Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6279152
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

PET Radiotracers: Executive Overview

PET radiotracers are positron-emitting compounds used with positron emission tomography to visualize biological processes, support diagnosis, characterize disease, and assess treatment response. The field combines radiochemistry, nuclear medicine, imaging technology, clinical evidence, regulation, and specialized logistics. Its development is shaped by demand for more precise, noninvasive molecular information and by the operational requirements of producing, handling, transporting, and administering short-lived radioactive products.

Clinical and Operational Shifts Reshaping PET Radiotracers

The landscape is shifting from a narrow focus on established diagnostic tracers toward broader use of targeted imaging agents for oncology, neurology, cardiology, and other areas of unmet clinical need. Greater emphasis is being placed on theranostic pathways, standardized interpretation, reproducible manufacturing, decentralized access, and evidence that connects imaging findings with treatment decisions. Short radionuclide half-lives continue to make cyclotron access, radiopharmacy capacity, quality systems, scheduling, and transport reliability central to adoption.

How Artificial Intelligence Is Influencing PET Radiotracer Use

Artificial intelligence is increasingly relevant across PET workflows, including image reconstruction, attenuation correction, denoising, lesion detection, segmentation, quantification, reporting support, and multimodal data integration. These applications may improve consistency and reduce manual workload, but their clinical value depends on representative training data, external validation, transparent performance evaluation, interoperability, and oversight of bias. AI does not remove the need for validated radiotracer production, qualified clinical interpretation, or regulatory compliance.

Regional Dynamics Across the PET Radiotracer Landscape

North America benefits from mature nuclear medicine infrastructure, specialized research centers, and established clinical pathways, while access can vary by geography and reimbursement conditions. Europe combines strong academic radiochemistry with diverse national approval, reimbursement, and supply arrangements. Asia-Pacific includes advanced imaging markets alongside rapidly expanding healthcare systems, creating varied levels of manufacturing capacity and access. Latin America is influenced by uneven infrastructure, import dependence, and concentration of specialist services. The Middle East is developing imaging capacity through major healthcare institutions and cross-border partnerships, while Africa faces pronounced constraints in radiopharmacy, equipment, trained personnel, and reliable distribution, alongside important opportunities for capacity building.

How ASEAN, BRICS, EU, G7, GCC, and NATO Shape Adoption

ASEAN economies show differing levels of PET access, regulation, and radiopharmacy capability, making regional cooperation and workforce development valuable. BRICS members span advanced and developing nuclear medicine systems, with collaboration potentially supporting local production, research, and technology transfer. The European Union benefits from scientific networks but must coordinate across national health systems and regulatory environments. G7 countries generally provide strong research and clinical infrastructure, although affordability and equitable access remain priorities. GCC states are investing in advanced healthcare capacity, while NATO members collectively include many established imaging systems but retain differences in procurement, reimbursement, and service availability.

Country-Level Priorities for PET Radiotracer Development

Australia combines advanced clinical research with geographic challenges in supplying short-lived products. Brazil and Mexico must address regional disparities, infrastructure, and access beyond major urban centers. Canada and the United States have substantial specialist capacity, with continued attention to reimbursement, logistics, and evidence generation. China and India are expanding nuclear medicine capabilities while navigating scale, quality assurance, and uneven regional access. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom have established research and clinical ecosystems, with priorities including innovation, workforce sustainability, health-system integration, and consistent patient access. Russia has relevant scientific and clinical capabilities, while infrastructure continuity, supply resilience, and regulatory conditions remain important considerations.

Practical Priorities for Industry and Healthcare Leaders

Leaders should align tracer development with clearly defined clinical decisions and prospectively planned evidence requirements. They should strengthen end-to-end quality systems, secure dependable radionuclide and precursor supply, and design distribution networks around half-life and patient scheduling constraints. Partnerships with hospitals, radiopharmacies, regulators, researchers, and payers can improve adoption readiness. Investment in training, validated digital tools, interoperable data, and responsible AI should accompany expansion. Access strategies should address rural and underserved populations rather than concentrating capability only in major centers.

Research Methodology for the PET Radiotracer Assessment

This executive summary uses the PET radiotracer market reference as a scope definition and synthesizes established, non-quantitative themes across clinical practice, radiochemistry, imaging technology, regulation, logistics, and regional healthcare infrastructure. Geographic discussion covers North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, together with the specified economic and political groupings and countries. Findings are framed as evidence-informed structural insights; no market estimates, shares, sizing, forecasts, or company-specific claims are included.

Conclusion: Building Reliable, Clinically Integrated PET Radiotracer Systems

PET radiotracers are advancing within a healthcare environment that increasingly values molecularly precise diagnosis and treatment guidance. Progress will depend not only on novel compounds, but also on reproducible manufacturing, resilient short-lived isotope logistics, skilled personnel, validated clinical evidence, responsible AI, and equitable delivery. Organizations that integrate scientific innovation with operational reliability and health-system needs will be better positioned to translate PET radiotracer capabilities into dependable patient care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. PET Radiotracer Market, by Tracer Type
7.1. Introduction
7.2. Companion Diagnostic
7.3. Diagnostic
7.4. Research Use Only
7.5. Theranostic
8. PET Radiotracer Market, by Isotope
8.1. Introduction
8.2. Carbon-11
8.2.1. Cyclotron Produced
8.2.2. Half-Life Category: Short
8.3. Copper-64
8.3.1. Cyclotron Produced
8.3.2. Half-Life Category: Medium
8.4. Fluorine-18
8.4.1. Cyclotron Produced
8.4.2. Half-Life Category: Medium
8.5. Gallium-68
8.5.1. Generator Produced
8.5.2. Half-Life Category: Short
8.6. Iodine-124
8.6.1. Half-Life Category: Long
8.6.2. Reactor Produced
9. PET Radiotracer Market, by Indication
9.1. Introduction
9.2. Cardiology
9.2.1. Myocardial Perfusion
9.2.2. Viability Assessment
9.3. Infection And Inflammation
9.4. Neurology
9.4.1. Alzheimer's Disease
9.4.2. Brain Tumor
9.4.3. Epilepsy
9.4.4. Parkinsonian Disorders
9.5. Oncology
9.5.1. Diagnosis
9.5.2. Recurrence Detection
9.5.3. Staging
9.5.4. Treatment Response Monitoring
10. PET Radiotracer Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributors
10.4. Radiopharmacy Service Providers
10.5. Third Party Logistics
11. PET Radiotracer Market, by End User
11.1. Introduction
11.2. Diagnostic Imaging Centers
11.3. Hospitals
11.3.1. Community Hospital
11.3.2. Tertiary Care Hospital
11.4. Nuclear Pharmacies
11.4.1. Centralized Radiopharmacy
11.4.2. On-Site Nuclear Pharmacy
11.5. Pharmaceutical And Biotech Companies
11.6. Research Institutes And CROs
12. PET Radiotracer Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. PET Radiotracer Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. PET Radiotracer Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. ABX Advanced Biochemical Compounds GmbH
16.2. Advanced Accelerator Applications S.A.
16.3. Blue Earth Diagnostics Ltd.
16.4. Cardinal Health, Inc.
16.5. Curium Pharma
16.6. Eckert & Ziegler AG
16.7. GE HealthCare Technologies Inc.
16.8. IBA Radiopharma Solutions S.A.
16.9. Jubilant Pharmova Limited
16.10. Lantheus Holdings, Inc.
16.11. Nordion Inc.
16.12. Siemens Healthineers AG
16.13. SOFIE Biosciences, Inc.
16.14. Telix Pharmaceuticals Limited
16.15. Yantai Dongcheng Pharmaceutical Group Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global PET Radiotracer Market, Years Considered for the Study
FIGURE 2. Global PET Radiotracer Market, Research Design
FIGURE 3. Global PET Radiotracer Market, Research Framework
FIGURE 4. Global PET Radiotracer Market, Data Triangulation
FIGURE 5. Global PET Radiotracer Market Size, 2017-2032 (USD Million)
FIGURE 6. Global PET Radiotracer Market Size, by Tracer Type, 2025 vs 2032 (%)
FIGURE 7. Global PET Radiotracer Market Size, by Tracer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global PET Radiotracer Market Size, by Isotope, 2025 vs 2032 (%)
FIGURE 9. Global PET Radiotracer Market Size, by Isotope, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global PET Radiotracer Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 11. Global PET Radiotracer Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global PET Radiotracer Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global PET Radiotracer Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global PET Radiotracer Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global PET Radiotracer Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global PET Radiotracer Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global PET Radiotracer Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global PET Radiotracer Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global PET Radiotracer Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global PET Radiotracer Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global PET Radiotracer Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global PET Radiotracer Market Segmentation & Coverage
TABLE 2. Global PET Radiotracer Market Size, 2017-2032 (USD Million)
TABLE 3. Global PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 4. Global Companion Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Companion Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Companion Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Research Use Only Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Research Use Only Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Research Use Only Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Theranostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Theranostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Theranostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 17. Global Carbon-11 Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Carbon-11 Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Carbon-11 Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Cyclotron Produced Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Cyclotron Produced Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Cyclotron Produced Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Half-Life Category: Short Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Half-Life Category: Short Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Half-Life Category: Short Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Copper-64 Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Copper-64 Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Copper-64 Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Cyclotron Produced Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Cyclotron Produced Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Cyclotron Produced Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Half-Life Category: Medium Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Half-Life Category: Medium Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Half-Life Category: Medium Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Fluorine-18 Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Fluorine-18 Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Fluorine-18 Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Cyclotron Produced Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Cyclotron Produced Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Cyclotron Produced Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Half-Life Category: Medium Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Half-Life Category: Medium Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Half-Life Category: Medium Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Gallium-68 Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Gallium-68 Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Gallium-68 Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Generator Produced Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Generator Produced Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Generator Produced Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Half-Life Category: Short Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Half-Life Category: Short Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Half-Life Category: Short Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Iodine-124 Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Iodine-124 Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Iodine-124 Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Half-Life Category: Long Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Half-Life Category: Long Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Half-Life Category: Long Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Reactor Produced Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Reactor Produced Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Reactor Produced Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 63. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Myocardial Perfusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Myocardial Perfusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Myocardial Perfusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Viability Assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Viability Assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Viability Assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Infection And Inflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Infection And Inflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Infection And Inflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Alzheimer's Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Alzheimer's Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Alzheimer's Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Brain Tumor Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Brain Tumor Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Brain Tumor Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Epilepsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Epilepsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Epilepsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Parkinsonian Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Parkinsonian Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Parkinsonian Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Recurrence Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Recurrence Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Recurrence Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Staging Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Staging Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Staging Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Treatment Response Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Treatment Response Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Treatment Response Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Radiopharmacy Service Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Radiopharmacy Service Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Radiopharmacy Service Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Third Party Logistics Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Third Party Logistics Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Third Party Logistics Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Community Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Community Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Community Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Tertiary Care Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Tertiary Care Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Tertiary Care Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Nuclear Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Nuclear Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Nuclear Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Centralized Radiopharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Centralized Radiopharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Centralized Radiopharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global On-Site Nuclear Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global On-Site Nuclear Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global On-Site Nuclear Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Pharmaceutical And Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Pharmaceutical And Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Pharmaceutical And Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Research Institutes And CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Research Institutes And CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Research Institutes And CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global PET Radiotracer Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific PET Radiotracer Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 163. North America PET Radiotracer Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. North America PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 165. North America PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 166. North America PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 167. North America PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 168. North America PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 169. North America PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 170. North America PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 171. North America PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 172. North America PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 173. North America PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 174. North America PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 175. North America PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. North America PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. North America PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 178. North America PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 179. Latin America PET Radiotracer Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Latin America PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 181. Latin America PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 182. Latin America PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 183. Latin America PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 184. Latin America PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 185. Latin America PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 186. Latin America PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 187. Latin America PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 188. Latin America PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 189. Latin America PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 190. Latin America PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 191. Latin America PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. Latin America PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Latin America PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 194. Latin America PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 195. Europe PET Radiotracer Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Europe PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 197. Europe PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 198. Europe PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 199. Europe PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 200. Europe PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 201. Europe PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 202. Europe PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 203. Europe PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 204. Europe PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 205. Europe PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 206. Europe PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 207. Europe PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. Europe PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Europe PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 210. Europe PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 211. Middle East PET Radiotracer Market Size, by Region, 2017-2032 (USD Million)
TABLE 212. Middle East PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 213. Middle East PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 214. Middle East PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 215. Middle East PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 216. Middle East PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 217. Middle East PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 218. Middle East PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 219. Middle East PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 220. Middle East PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 221. Middle East PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 222. Middle East PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 223. Middle East PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Middle East PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Middle East PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 226. Middle East PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 227. Africa PET Radiotracer Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. Africa PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 229. Africa PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 230. Africa PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 231. Africa PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 232. Africa PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 233. Africa PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 234. Africa PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 235. Africa PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 236. Africa PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 237. Africa PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 238. Africa PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 239. Africa PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 240. Africa PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Africa PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 242. Africa PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 243. Global PET Radiotracer Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. ASEAN PET Radiotracer Market Size, by Group, 2017-2032 (USD Million)
TABLE 245. ASEAN PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 246. ASEAN PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 247. ASEAN PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 248. ASEAN PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 249. ASEAN PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 250. ASEAN PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 251. ASEAN PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 252. ASEAN PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 253. ASEAN PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 254. ASEAN PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 255. ASEAN PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 256. ASEAN PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 257. ASEAN PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. ASEAN PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 259. ASEAN PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 260. GCC PET Radiotracer Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. GCC PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 262. GCC PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 263. GCC PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 264. GCC PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 265. GCC PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 266. GCC PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 267. GCC PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 268. GCC PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 269. GCC PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 270. GCC PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 271. GCC PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 272. GCC PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 273. GCC PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. GCC PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 275. GCC PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 276. European Union PET Radiotracer Market Size, by Group, 2017-2032 (USD Million)
TABLE 277. European Union PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 278. European Union PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 279. European Union PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 280. European Union PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 281. European Union PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 282. European Union PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 283. European Union PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 284. European Union PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 285. European Union PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 286. European Union PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 287. European Union PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 288. European Union PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 289. European Union PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. European Union PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 291. European Union PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 292. BRICS PET Radiotracer Market Size, by Group, 2017-2032 (USD Million)
TABLE 293. BRICS PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 294. BRICS PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 295. BRICS PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 296. BRICS PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 297. BRICS PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 298. BRICS PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 299. BRICS PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 300. BRICS PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 301. BRICS PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 302. BRICS PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 303. BRICS PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 304. BRICS PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 305. BRICS PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. BRICS PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 307. BRICS PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 308. G7 PET Radiotracer Market Size, by Group, 2017-2032 (USD Million)
TABLE 309. G7 PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 310. G7 PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 311. G7 PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 312. G7 PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 313. G7 PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 314. G7 PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 315. G7 PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 316. G7 PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 317. G7 PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 318. G7 PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 319. G7 PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 320. G7 PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 321. G7 PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. G7 PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 323. G7 PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 324. NATO PET Radiotracer Market Size, by Group, 2017-2032 (USD Million)
TABLE 325. NATO PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 326. NATO PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 327. NATO PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 328. NATO PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 329. NATO PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 330. NATO PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 331. NATO PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 332. NATO PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 333. NATO PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 334. NATO PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 335. NATO PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 336. NATO PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 337. NATO PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 338. NATO PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 339. NATO PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 340. Global PET Radiotracer Market Size, by Country, 2017-2032 (USD Million)
TABLE 341. United States PET Radiotracer Market Size, 2017-2032 (USD Million)
TABLE 342. United States PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 343. United States PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 344. United States PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 345. United States PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 346. United States PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 347. United States PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 348. United States PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 349. United States PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 350. United States PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 351. United States PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 352. United States PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 353. United States PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 354. United States PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 355. United States PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 356. United States PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 357. Canada PET Radiotracer Market Size, 2017-2032 (USD Million)
TABLE 358. Canada PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 359. Canada PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 360. Canada PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 361. Canada PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 362. Canada PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 363. Canada PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD Million)
TABLE 364. Canada PET Radiotracer Market Size, by Iodine-124, 2017-2032 (USD Million)
TABLE 365. Canada PET Radiotracer Market Size, by Indication, 2017-2032 (USD Million)
TABLE 366. Canada PET Radiotracer Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 367. Canada PET Radiotracer Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 368. Canada PET Radiotracer Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 369. Canada PET Radiotracer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 370. Canada PET Radiotracer Market Size, by End User, 2017-2032 (USD Million)
TABLE 371. Canada PET Radiotracer Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 372. Canada PET Radiotracer Market Size, by Nuclear Pharmacies, 2017-2032 (USD Million)
TABLE 373. Mexico PET Radiotracer Market Size, 2017-2032 (USD Million)
TABLE 374. Mexico PET Radiotracer Market Size, by Tracer Type, 2017-2032 (USD Million)
TABLE 375. Mexico PET Radiotracer Market Size, by Isotope, 2017-2032 (USD Million)
TABLE 376. Mexico PET Radiotracer Market Size, by Carbon-11, 2017-2032 (USD Million)
TABLE 377. Mexico PET Radiotracer Market Size, by Copper-64, 2017-2032 (USD Million)
TABLE 378. Mexico PET Radiotracer Market Size, by Fluorine-18, 2017-2032 (USD Million)
TABLE 379. Mexico PET Radiotracer Market Size, by Gallium-68, 2017-2032 (USD M

Companies Mentioned

  • ABX Advanced Biochemical Compounds GmbH
  • Advanced Accelerator Applications S.A.
  • Blue Earth Diagnostics Ltd.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler AG
  • GE HealthCare Technologies Inc.
  • IBA Radiopharma Solutions S.A.
  • Jubilant Pharmova Limited
  • Lantheus Holdings, Inc.
  • Nordion Inc.
  • Siemens Healthineers AG
  • SOFIE Biosciences, Inc.
  • Telix Pharmaceuticals Limited
  • Yantai Dongcheng Pharmaceutical Group Co., Ltd.

Related Reports

Medicinal Radiocompounds Market - Global Forecast 2026-2032 - Product Image

Medicinal Radiocompounds Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Diagnostic Radiopharmaceuticals for Alzheimer Disease Market - Global Forecast 2026-2032 - Product Image

Diagnostic Radiopharmaceuticals for Alzheimer Disease Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Positron Emission Tomography Market - Global Forecast 2026-2032 - Product Image

Positron Emission Tomography Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Nuclear Radiopharmaceutical Market - Global Forecast 2026-2032 - Product Image

Nuclear Radiopharmaceutical Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
PET Radiotracer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

PET Radiotracer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.